- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af China Academy of Chinese Medical Sciences
I alt 1997 resultater
-
Cancer Institute and Hospital, Chinese Academy...UkendtTredobbelt negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...UkendtHIV-infektion | HPV-infektion | SyfilisKina
-
Cancer Institute and Hospital, Chinese Academy...UkendtLivmoderhalskræft | HPV-infektioner | Precancerøs sygdom i livmoderhalsen | HPV-relaterede sygdomme
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoterapi | Immunterapi | Kemoradioterapi | NimotuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEndometriekarcinom | Tilbagevendende eller metastatisk | TP53 mutationKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuTrippel-negativ brystkræft i tidligt stadium med BRCA1/2-mutationerKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLipider | Ung brystkræftpatient | Anti-tumor lægemiddelterapi
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAdenocarcinom i bugspytkirtlen | Avanceret kræft | Stofbrug | Capecitabin | Oxaliplatin | Første linje | Cadonilimab | Nanoliposomal irinotecanKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuBugspytkirtelkræft
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHepatocellulært karcinom | Strålebehandling | Tislelizumab | Tumor tromboseKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuIkke småcellet lungekræft | ERBB2 mutationsrelaterede tumorer | Disitamab Vedotin | ERBB2 genduplikering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Pan XiangbinRekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt tilbagevendende tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMålrettet terapi | HR+/HER2- Avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret lungekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystkræft | Kemoterapi effektKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringNasopharyngealt karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPatienter med avancerede solide tumorerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSarkom, blødt væv | Bagagerum | Ekstremitet | Intensitetsmoduleret strålebehandling | Større sårkomplikationer | Målrettet terapiKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHormonreceptor positiv avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuRefraktær lymfom | DLBCL | MYD88 genmutation | Tilbagefald | CD79A genmutation | CD79B genmutation
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuHepatocellulært karcinom resektabelt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEsophageal pladecellekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoradiation | Kirurgi | Kemoterapi effekt | Immunterapi | Målrettet terapi | Esophagogastric Juction CancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avanceret ikke-småcellet lungekræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret hepatocellulært karcinom | Strålebehandling | Sorafenib | ToripalimabKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringUbehandlede avancerede NSCLC-patienter | FISH Identificeret ALK Fusion Positiv eller NegativKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTredobbelt negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTredobbelt negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHER2-positiv brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSamtidig kemoradioterapi | Nasopharynx pladecellekarcinom | Fase II, III | Induktionskemoterapi | Reducer behandlingsintensitetenKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuHepatocellulært karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLokalt avanceret bugspytkirtelkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystneoplasmer | Neoplasma gentagelse, lokalKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringGenetik | Sundhedsadfærd | TyndhedKina